The Long-Term Survival of Patients with Metastatic Prostate Cancer
Mike Scott who writes the THE “NEW” PROSTATE CANCER INFOLINK today published an excellent summary/discussion about survival time for men with metastatic prostate cancer. He presents a synopsis about anticipated survival going back to the [...]
Salvage Radiotherapy (SRT) After High-Intensity Focused Ultrasound (HIFU) for Recurrent Localized Prostate Cancer
The use of high-intensity focused ultrasound (HIFU) for the primary treatment of prostate cancer will probably become more common in the very near future. HIFU has been used for many years in Europe and Mexico [...]
Phase II trial Combining Bevacizumab, Thalidomide, Docetaxel, and Prednisone in Men with Metastatic Castration-Resistant Prostate Cancer
Dr. Yang-Min Ning and collaborators reported, in the April 20, 2010 issue of the Journal of Clinical Oncology, a Phase II trial which combined chemotherapy (docetaxel) with an anti-angiogenesis drug for men with castration-resistant prostate [...]
Statin Drugs Lower the Risk of a Recurrence, but Not Without Risk
Statin drugs improve blood cholesterol levels, but they also cause problems. They also seem to lower the risk of prostate cancer recurrences post surgery by as much as 30% according to researchers at Duke University. [...]
Medicare Funding for Provenge, We Urgently Need Your HELP
How are funding decisions made for Medicare and Medicaid? What drugs are to be funded? These questions have recently come to our attention as many of us have attempted to have Medicare fund our use [...]
Unlocking the Genetic Code of Prostate Cancer for Better Treatments
Yesterdays Wall Street Journal publish a very important piece by Melinda Beck in their Health Journal (http://tinyurl.com/2dtrrll) . Everyone should go to the piece and read it. The piece, The Prostate Cancer Quandary, has received [...]